Veena Delivery Systems, Inc., (“iVeena”) a clinical-stage ophthalmic biopharmaceutical company, today announced the successful completion of its Phase 1 clinical trial evaluating the safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results